Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 13c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.45), $0.13 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• CrowdStrike (CRWD) PT Raised to $300 at Truist Securities
• Goldman Sachs on Kingsoft Cloud (KC): 'AI cloud to drive revenue expansion with attractive investment payback'